Mölnlycke sets sail with ocean biofuel: A step towards greener logistics

Longstanding partners, Mölnlycke Health Care and Scan Global Logistics (SGL), have entered an agreement for the purchase and deployment of ocean biofuel covering trade lanes from Asia to Europe to further reduce carbon emissions. This decision supports the global MedTech company Mölnlycke's commitment to reducing greenhouse gas (GHG) emissions and reaching Net Zero by 2050.
For over 15 years, Scan Global Logistics have had a close global partnership with Mölnlycke, marked by a shared focus on supply chain optimisation and mitigating greenhouse gas (GHG) emissions associated with maritime transportation. In recent years, this collaboration has seen a heightened emphasis on sustainability initiatives, culminating in exploring actions to reduce environmental impact, which resulted in the company now buying ocean biofuel.
Eric de Kesel, COO & EVP Sustainability, Mölnlycke, elaborates on this decision:
“We are committed to driving our sustainability efforts forward and firmly believe we can reduce emissions while maintaining the quality of our business operations. The partnership with Scan Global Logistics to purchase a significant amount of biofuel for our ocean shipments is important and beneficial from a business, economic, and environmental standpoint, particularly for our Asia-Europe routes.”
Striking a balance: Sustainable and economical solutions in logistics
Both companies recognise the importance of offering tangible solutions to address climate change-related concerns, anchoring their collaboration in a mutual commitment to push for positive change.
Kim Fischer, Corporate EVP, Global Sales & Corporate Strategic Accounts in Scan Global Logistics, reinforces this commitment:
“Mölnlycke is very important to us, and our relationship dates back over a decade. This initiative underlines the dynamic and innovative approach that both companies are investing in a successful business collaboration. Further sustainability initiatives have already been discussed with Mölnlycke, and we value such entrepreneurship, which aligns with our business approach.”
Marc Bach Spangsberg Sørensen, Global Head of Program Management at Scan Global Logistics, continues:
”We are dedicated to expanding the portfolio of relevant products offered to our customers in an ever-changing world. Through strategic collaborations, we promote the agenda for alternative fuel types, contributing to the long-term transition to low-emisssion transport solutions.”
Central to this collaboration is the ability to provide customers like Mölnlycke with accessible, measurable, and ready-for-use products that facilitate GHG emission reduction. By leveraging biofuel for ocean freight, SGL aim to deliver environmental and economic benefits through cost-effective pricing structures.
Partnerhips as drivers for positive change
Martin Andersen, Global Head of Sustainability & ESG at Scan Global Logistics, is excited about the collective courage among companies which will support the demand for ocean biofuel and actual emission reductions:
”It is paramount and uplifting to see responsible companies drive their decarbonisation journey. It is a challenge, but we all must contribute and support each other with collaboration across industries and supply chains, which is essential to making progress. The window for meaningful change is closing; now is the time to drive collective courage for a low-carbon future.”
In conclusion, this partnership for ocean biofuel represents a positive step towards low-carbon logistics.
While navigating the complexities of modern logistics, collaborations like these serve as examples of optimism and pave the way towards a more sustainable future for the industry.
Latest press releases
Go to Media room-
Mölnlycke Health Care annual report 2025 highlights sustainable growth and strategic transformation
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.
-
Europe faces a growing chronic wound crisis – time to act is now
Gothenburg, Sweden. 31 March 2026. Mölnlycke®, a global leader in MedTech, today welcomes the publication of Shaping the future of wound care in Europe, the first joint industry white paper from the MedTech Europe Wound Care Sector Working Group. The wound paper highlights the growing burden of chronic wounds and urges EU policymakers to elevate wound care as a strategic health priority across the EU.
-
Mölnlycke Health Care AB: CEO, Zlatko Rihter, announces resignation, Guillaume Joucla appointed interim CEO
Tue, Mar 24, 2026 Today, it was announced that Zlatko Rihter, CEO of Mölnlycke Health Care, has informed the Board of Directors of his decision to resign. Following his decision, Guillaume Joucla, Chief Financial Officer, has been appointed interim CEO of Mölnlycke Health Care. Mölnlycke’s Board has initiated the recruitment process for a permanent CEO.
-
Mölnlycke joins National Climate Initiative within healthcare and life science
A broad public–private partnership is now being launched to accelerate the green transition within the Swedish healthcare and life science sector. The initiative aims, through collaboration, to reduce greenhouse gas emissions with the ambition of reaching net zero across the entire value chain by 2045.
-
Mölnlycke® celebrates 100 million ProcedurePak® trays - advancing operating room efficiency worldwide
Gothenburg, Sweden. 27 January 2026. Mölnlycke Health Care, a global leader in Medtech, headquarted in Gothenburg, Sweden, is celebrating the production of 100 million ProcedurePak® trays at the company's production sites in the Czech Republic.
-
Mölnlycke donates patent to spark innovation in sustainable healthcare
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.
-
Mölnlycke establishes first wound care manufacturing site in China
Changshu, China, and Gothenburg, Sweden. 5 November 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets.
-
Mölnlycke Health Care’s global headquarters ranked number one workplace in Sweden and top 20 globally in Leesman workplace experience survey
Gothenburg, Sweden, 15 October 2025 Mölnlycke® Health Care is proud to announce that its global headquarters have placed number one in Sweden, and top 20 globally, in the prestigious Leesman® Index, a benchmark survey measuring workplace experience across thousands of organisations worldwide.
-
Mölnlycke Health Care breaks ground on $135 million expansion of Wound Care manufacturing facility in Brunswick, Maine
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.